`Case 2:19-cv-10227-VAP-JEM Document 49 Filed 12/03/20 Page 1 of 1 Page ID #:320
`
`UNITED STATES DISTRICT COURT
`
`CENTRAL DISTRICT OF CALIFORNIA
`
`CIVIL MINUTES - GENERAL
`
`3:59
`
`2:19-cv-10227-VAP-JEMx
`
`Date December 3, 2020
`
`Title Michelene Colette et al. v. CV Sciences, Inc.
`
`
`
`Present: The Honorable VIRGINIA A. PHILLIPS, UNITED STATES DISTRICT JUDGE
`
`DAISY ROJAS
`
`Deputy Clerk
`
`Not Reported
`
`Court Reporter
`
`Attorney(s) Present for Plaintiff(s):
`
`Attorney(s) Present for Defendant(s):
`
`None Present
`
`None Present
`
`Proceedings: MINUTE ORDER DENYING PLAINTIFFS’ REQUEST TO LIFT STAY [DKT. 48]
`(IN CHAMBERS)
`
`Before the Court is Defendant CV Sciences, Inc. (“Defendant”) and
`Plaintiffs Michelene Colette and Leticia Shaw’s (“Plaintiffs") Joint Status Report.
`(Dkt. 48). Plaintiffs request that the Court lift the stay imposed in the Court’s May
`22, 2020 Order.
`(Dkt. 46). Defendant maintains that a lift of the stay is
`premature. For the reasons set forth below, the Court declines to lift the stay.
`
`Plaintiffs claim the stay should be lifted because the FDA “has no plans to
`legalize any CBD consumer products absent a formal drug approval process...
`[and] even in the highly unlikely event the FDA does make CBD supplements and
`food with CBD legal, it is certainly not going to do so retroactively.” (Dkt. 48, at
`2). Plaintiffs’ arguments are speculative and unavailing. Plaintiffs have failed to
`provide any evidence supporting their statements about the FDA's alleged plans,
`or lack thereof, to legalize CBD- Accordingly, the case will remain STAYED until
`the FDA completes its rulemaking regarding the marketing, including labeling, of
`CBD ingestible products-
`
`IT IS SO ORDERED.
`
`Page 1 of 1
`
`CIVIL MINUTES — GENERAL
`
`Initials of Deputy Clerk DR
`
`